Long-term follow-up of central serous chorioretinopathy. - Wikidata - wikimedia - TriplyDB

Long-term follow-up of central serous chorioretinopathy.

Long-term follow-up of central serous chorioretinopathy.

http://www.wikidata.org/entity/Q33643688

about

Advances in the treatment of central serous chorioretinopathy Indocyanine green-mediated photothrombosis as a new technique of treatment for persistent central serous chorioretinopathy.Topical nepafenac in treatment of acute central serous chorioretinopathy.Large-spot subthreshold transpupillary thermotherapy for chronic serous macular detachment Hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy.Transpupillary thermotherapy for atypical central serous chorioretinopathy.Type A behavior and central serous chorioretinopathy.Retinal sensitivity assessed by microperimetry and corresponding retinal structure and thickness in resolved central serous chorioretinopathy.Diagnosis and interventions for central serous chorioretinopathy: review and update.High-dose antioxidants for central serous chorioretinopathy; the randomized placebo-controlled study.Central serous chorioretinopathy: update on pathophysiology and treatment.Factors influencing the visual acuity of chronic central serous chorioretinopathy Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome Acute visual loss induced by dexamethasone during neoadjuvant docetaxol.System review and meta-analysis on photodynamic therapy in central serous chorioretinopathy.Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial.Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy.Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy.Comparison of Serum Cortisol and Testosterone Levels in Acute and Chronic Central Serous Chorioretinopathy A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).Indocyanine green angiography in chronic central serous chorioretinopathy Angiographic characteristics of central serous chorioretinopathy in an Egyptian population.Visual loss from central serous retinopathy in systemic lupus erythematosus.Choroidal and Retinal Abnormalities by Optical Coherence Tomography in Endogenous Cushing's Syndrome.En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy Persistent subretinal fluid after surgery for rhegmatogenous retinal detachment: hypothesis and review.Central serous chorioretinopathy: a review of epidemiology and pathophysiology.Diagnosed a Patient with Central Serous Chorioretinopathy? Now What?: Management of Central Serous Chorioretinopathy.Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy.Long-term results and recurrence rates after spironolactone treatment in non-resolving central serous chorio-retinopathy (CSCR).Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: A 3-year follow-up study.Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy.Sudden Visual Loss In A Young Man.Low-dose aspirin as treatment for central serous chorioretinopathy Photodynamic therapy and central serous chorioretinopathy.Alterations in "in vivo" histology of retina in bilateral chronic central serous chorioretinopathy after intravitreal bevacizumab.Central serous chorioretinopathy and antiphospholipid antibodies--results of a pilot study.

P2860

Q28088443-E6A91408-C374-408F-8DF4-2A63A18DA862 Q30905661-C48B8602-8BCF-4EF1-8D3C-43A424459C47 Q33597082-9F209EE7-66F4-4AF5-9822-EC14BD28A28D Q33863641-0173B5DD-6026-438E-B90E-FF6D1D72E72A Q34036539-B62A8BA8-A097-41FF-A72A-1F3D035998E9 Q34158234-06977B55-A0A8-4B26-A855-A5A2D63914F9 Q34165060-464F1A9A-0AC9-4225-95B5-CCF1C9DFD397 Q34325619-FC34DC61-2CC9-47BE-89B1-09E3C37F9A93 Q34334335-11CEECCD-FDF3-462C-BEF1-9A3C75E2FAE0 Q34338611-E0DB7B75-8B53-4573-8901-D2DE42F19B34 Q34587658-E6E5E836-FACB-4A01-8C44-89C42F7605A7 Q34695063-3C9DA045-4FCF-4F00-8244-7C661E0B2D4C Q35088788-C2D1CFEB-59FD-4874-8139-14F8E7A9D030 Q35180971-77129C17-91FD-4736-8345-AD03EFDD64CA Q35209632-1D0F9AF4-5FF4-4967-B537-371E5FC8F4A8 Q35782233-A7F333E8-6309-495C-87FA-1F2B4D1C0048 Q35869490-D4B82063-FA21-489A-A0DD-273179B8E48A Q35955614-65E08B01-10B0-4FBC-AE28-B58B258406F8 Q36071607-B77B0D63-058D-4F78-82CF-DC6679146210 Q36304949-79DC62DF-9BCA-4778-A751-C0914109C5A9 Q36342988-53C15916-D1CE-4303-B5E4-F7D93B644225 Q36379671-D97B8DBD-5212-4C35-8DE6-C9E6B859B3CE Q36407625-49F1341A-3871-4815-AFBA-C5E515BF5F51 Q36576875-58E8DE3F-0E0A-4E65-824E-AB881437D9C2 Q36955739-9193958E-345F-4382-9FB7-09A5FB91928C Q37477287-3FCCCE6E-28D3-447B-BA45-29FCB7596989 Q37486699-BABA1D01-58E7-49AD-ACF6-6722E8CA6BD1 Q37619588-5FF82DD4-994E-43B3-8E6B-F4BEA2DB1F68 Q37974820-6494E8D4-4B5E-4312-98E2-19B5F459B2C8 Q38025702-67C71E2A-0F00-415A-8983-6482945BA238 Q38644045-EAF0A520-0B19-495C-A92F-5F696FE9C87E Q39530010-5EE85639-11B1-4BDB-92B0-F334E2451BAA Q39541652-26A54030-8DC1-4D13-8FDB-44DA0F5FC52E Q41106280-2D0C5F29-437C-4205-8FDF-6037D280E386 Q41746219-BE2287BF-4A66-4D0A-B69C-562AEED70511 Q41885930-1AAD7C34-54A7-4FAA-B3D8-E9D97DD78F1D Q41899388-232E789C-7E77-4EDE-9DB9-39134A0B0E24 Q41990230-29F95A99-D1F0-4835-9BA0-F0DAAF88759F Q42225108-E8F4D4F7-45C4-4749-8D5E-A46A84B8349C Q44787262-E4C3E545-26D9-4CE8-A9DA-7E1EEF6A18A3

P2860

Long-term follow-up of central serous chorioretinopathy.

http://www.wikidata.org/entity/Q33643688

description

1984 nî lūn-bûn

@nan

1984 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1984 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1984年の論文

@ja

1984年学术文章

@wuu

1984年学术文章

@zh-cn

1984年学术文章

@zh-hans

1984年学术文章

@zh-my

1984年学术文章

@zh-sg

1984年學術文章

@yue

name

Long-term follow-up of central serous chorioretinopathy.

@ast

Long-term follow-up of central serous chorioretinopathy.

@en

type

label

Long-term follow-up of central serous chorioretinopathy.

@ast

Long-term follow-up of central serous chorioretinopathy.

@en

prefLabel

Long-term follow-up of central serous chorioretinopathy.

@ast

Long-term follow-up of central serous chorioretinopathy.

@en

P1433

Q33643688-9CBCAC5A-3367-4450-9098-9427DB330A5F

P1476

Q33643688-33BF2CCC-617F-48F6-B85B-640002AF1904

P2093

Q33643688-684A4B4B-0CD5-4089-9136-6D128853E353

Q33643688-6E4C65CB-7F97-4D5D-9F29-8198DAEBE67C

Q33643688-AC58D68D-3C87-4394-8763-0F04401CC2F6

Q33643688-E6B5B192-75D9-4280-A185-8F9FE736E6A7

P2860

Q33643688-0955BB57-EC77-4B60-8595-379D8F3E99BD

Q33643688-1DA45643-7E40-4FBF-8218-4B2FCF0850EA

Q33643688-298A8D29-DD45-4702-8A1D-FC942AAD85F3

Q33643688-63E23795-8E04-41D1-907D-88C48F30F8A1

Q33643688-7C6E0826-9FC0-49D9-BDDA-50C311612B35

Q33643688-B0ABE97D-DA2D-46AC-99D1-67DEA3E80BD1

Q33643688-D8CE698E-0012-4AFF-BD28-9B7FD3C60427

Q33643688-F3E545A5-0C94-4CFD-A64C-04BDB6D78A1D

P304

Q33643688-0ABD0714-839F-4A51-AB93-F9DE3F437424

P31

Q33643688-FA79C816-AD86-48B5-A235-289DAF908DC4

P356

Q33643688-31881B12-67DF-4882-A39C-889661968E48

P407

Q33643688-B8BCD523-3994-49CE-A707-C0E59EF4A984

P433

Q33643688-6C9ECBA1-4B13-4F0E-8E2B-10F588A6D37B

P478

Q33643688-5F5577DC-49C1-449C-A5A1-A6318F2625AB

P577

Q33643688-32D7B50F-99FE-4045-805E-7F5C0326E976

P5875

Q33643688-941AB26E-019B-4A8C-B4FD-0E5A2411D327

P698

Q33643688-B844AF4E-12B0-4243-8B1C-9DC8698F9B42

P932

Q33643688-F3A90B0D-4A30-44A9-9899-90D0E06AED51

P356

P1433

British Journal of Ophthalmology

P1476

Long-term follow-up of central serous chorioretinopathy.

@en

P2093

Fine SL

http://www.w3.org/2001/XMLSchema#string

Gilbert CM

http://www.w3.org/2001/XMLSchema#string

Owens SL

http://www.w3.org/2001/XMLSchema#string

Smith PD

http://www.w3.org/2001/XMLSchema#string

P2860

Argon laser photocoagulation in the treatment of central serous retinopathy.

Central serous retinopathy.

Subretinal neovascularization following argon laser photocoagulation treatment for central serous chorioretinopathy: complication or misdiagnosis?

Argon laser treatment of central serous chorioretinopathy.

Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy.

Direct and indirect laser photocoagulation of central serous choroidopathy.

Long-term follow-up of central serous retinopathy.

Central angiospastic retinopathy.

P304

815-820

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.68.11.815

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

1984-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

16654252

http://www.w3.org/2001/XMLSchema#string

P698

6541945

http://www.w3.org/2001/XMLSchema#string

P932

1040477

http://www.w3.org/2001/XMLSchema#string